Flow-controlled One-lung Ventilation During Carinal Sleeve Reconstruction: Anaesthetic Management and Technical Feasibility. [PDF]
Turk J Anaesthesiol ReanimKılınç Berktaş C +3 more
europepmc +1 more source
Apneic oxygen insufflation decreases the incidence of hypoxemia during one-lung ventilation in open and thoracoscopic pulmonary lobectomy: A randomized controlled trial [PDF]
, 2017 Dae Myung Jung +6 more
openalex +1 more source
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu +3 more
wiley +1 more source
Oxygen reserve index for safer oxygen titration: beyond SpO2 in pediatric one-lung ventilation. [PDF]
Korean J AnesthesiolShin WJ.
europepmc +1 more source
Increased Total Positive End-Expiratory Pressure Does Not Improve Hypoxemia during One-Lung Ventilation [PDF]
, 2002 Kimio Yokota, Atsuo Sari
openalex +1 more source
Biomarkers of lung congestion and injury in acute heart failure
ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi +9 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot +8 more
wiley +1 more source
Comparison of two-lung ventilation with CO₂ artificial pneumothorax and one-lung ventilation during esophagectomy: a retrospective cohort study. [PDF]
BMC AnesthesiolLi C, Shen J, Yang L, Chen C.
europepmc +1 more source
A systematic review of one-lung ventilation during thoracic surgery comparing the safety and efficacy of high and low tidal volumes [PDF]
, 2015 Julian Camilleri‐Brennan +8 more
openalex +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source